C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,649 | 73,114 | 89,659 | 126,590 | 60,971 |
| Marketable Securities | 195,992 | 190,984 | 168,533 | 127,091 | 155,598 |
| Receivables | 10,341 | 1,167 | 13,599 | 11,799 | 500 |
| TOTAL | $273,228 | $276,044 | $279,592 | $271,189 | $223,686 |
| Non-Current Assets | |||||
| PPE Net | 6,206 | 6,571 | 6,756 | 7,132 | 7,290 |
| Investments And Advances | 28,759 | 31,637 | 40,975 | 28,008 | 29,857 |
| Other Non-Current Assets | 67,867 | 66,841 | 71,048 | 70,122 | 72,180 |
| TOTAL | $102,832 | $105,049 | $118,779 | $105,262 | $109,327 |
| Total Assets | $376,060 | $381,093 | $398,371 | $376,451 | $333,013 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,504 | 913 | 1,630 | 1,446 | 1,276 |
| Accrued Expenses | 15,388 | 11,203 | 12,891 | 20,630 | 15,484 |
| TOTAL | $43,293 | $54,201 | $55,018 | $42,766 | $30,271 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 20,769 | 36,592 | 35,142 | 15,471 | 8,424 |
| Other Non-Current Liabilities | 61,463 | 62,924 | 64,365 | 65,757 | 67,095 |
| TOTAL | $90,111 | $79,834 | $85,071 | $87,571 | $86,718 |
| Total Liabilities | $133,404 | $134,035 | $140,089 | $130,337 | $116,989 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,589 | 69,338 | 68,806 | 68,601 | 49,281 |
| Common Shares | 7 | 7 | 7 | 6 | 5 |
| Retained earnings | -599,126 | -574,460 | -556,744 | -528,383 | -493,629 |
| Other shareholders' equity | 455 | -440 | -380 | -127 | -904 |
| TOTAL | $242,656 | $247,058 | $258,282 | $246,114 | $216,024 |
| Total Liabilities And Equity | $376,060 | $381,093 | $398,371 | $376,451 | $333,013 |